The Prerequisites for Central Tolerance Induction against Citrullinated Proteins in the Mouse

Robby Engelmann; Andra Biemelt; Antje Cordshagen; Anja Johl; Daniela Kuthning; Brigitte Müller-Hilke

doi:10.1371/journal.pone.0158773

Abstract

Objectives

To assess the prerequisites for negative selection of peptidylcitrulline-specific T cells in the thymus. In detail, we here analyzed murine medullary thymic epithelial cells for the expression of peptidylarginine deiminases (PAD) and subsequent citrullination.

Methods

Medullary thymic epithelial cells were sorted, their mRNA was isolated and the expression of Pad genes was analyzed by quantitative PCR. Citrullination was detected by Western Blot in lysates of sorted medullary thymic epithelial cells and histologically by immunofluorescence of thymic thin sections.

Results

Pad2 and Pad4 are the main Pad isoforms expressed in mature medullary thymic epithelial cells of the mouse and their levels of expression are comparable to that of insulin (Ins2), another highly and promiscuously expressed protein in the thymus. Citrullination was detected in medullary thymic epithelial cells as shown by Western Blot and immunofluorescence.

Conclusions

Even though we here show that the murine thymus harbors the prerequisites for central tolerance to PAD and citrullinated peptides, it remains an open question whether the emergence of peptidylcitrulline-specific T cells and of autoantibodies recognizing citrullinated epitopes is caused by a failure of central or peripheral tolerance mechanisms.

Citation: Engelmann R, Biemelt A, Cordshagen A, Johl A, Kuthning D, Müller-Hilke B (2016) The Prerequisites for Central Tolerance Induction against Citrullinated Proteins in the Mouse. PLoS ONE 11(6): e0158773. https://doi.org/10.1371/journal.pone.0158773

Editor: Geraldo A. Passos, University of São Paulo, BRAZIL

Received: April 18, 2016; Accepted: June 21, 2016; Published: June 30, 2016

Copyright: © 2016 Engelmann et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Data Availability: All relevant data are within the paper and its Supporting Information files.

Funding: The work was supported by a grant of the Fritz Thyssen foundation (http://www.fritz-thyssen-stiftung.de/foerderung/gefoerderte-vorhaben/projekt/pl/pad-gene-und-citrullinierung/p/647/?no_cache). The grant 10.12.2.146 was passed to RE. Furthermore, the project was supported by an intramural grant (FORUN 889018-2013; https://www.med.uni-rostock.de/forschung-lehre/forschung/interne-foerderung/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Competing interests: The authors have declared that no competing interests exist.

Introduction

The presence of an autoimmune response against citrullinated epitopes is a hallmark of rheumatoid arthritis (RA). Indeed, a subset of RA patients is characterized by a distinct pattern of genetic and environmental risk factors associated with the development of antibodies against citrullinated peptide antigens (ACPA) [1]. These autoantibodies recognize citrullinated proteins that results from the posttranslational modification of arginine to citrulline. This citrullination is catalyzed by either of five isoforms of peptidylarginine deiminases (PAD) that show specific tissue distributions as well as substrate specificities [2–3]. Interestingly, while the citrullination itself is a physiological process frequently associated with inflammation [4], it is the appearance of ACPA that marks the transition to pathophysiology and RA [5].

In animal models for RA, the immunization with collagen type II in combination with complete Freund's adjuvant leads to a breakdown in tolerance, the production of ACPA and subsequent arthritis [6]. Of note, immunizing susceptible mice with citrullinated collagen was shown to induce a more severe arthritis than using native collagen and even the injection of citrullinated collagen alone, in the absence of any adjuvant, initiated arthritis [7–9]. As of yet, it is unknown why peptidylcitrulline-specific immune cells are not subjected to immune tolerance.

Immune tolerance is established at various levels during T and B cell development. As for the autoreactive T cells, central tolerance mechanisms within the thymus lead to a first wave of negative selection and elimination from the repertoire. Medullary thymic epithelial cells (mTEC) take on an important role in this process [10]. Mature mTECs express the transcriptional regulator AIRE (AutoImmune REgulator), that drives the promiscuous expression of otherwise tissue-restricted genes like e.g insulin [11–12]. During intrathymic selection, the presentation of MHC-self antigen complexes eliminates self-reactive T cells from the TCR repertoire and, by a still unclear mechanism, promotes the positive selection of self-specific regulatory T cells [13]. These regulatory T cells are essential for tolerance mechanisms in the periphery where they control autoreactive T cells that either evaded the negative selection in the thymus or recognize neo-epitopes that result from post-translational modifications [14].

We here set out to investigate whether the breach of tolerance towards citrullinated peptide antigens—as observed in RA patients and animal models of RA—can be attributed to the absence of central tolerance mechanisms. To that extent, we turned to the mouse and assessed both, the promiscuous PAD expression and citrullination in the thymus. We show that the prerequisites for central tolerance mechanisms to take effects against peptidylcitrulline-specific T cells are met.

Methods

Ethics Statement

All animal experiments were performed in accordance with the guidelines of the local animal use and care committee. Approval for these animal experiments by the “Landesamt für Landwirtschaft, Lebensmittelsicherheit und Fischerei Mecklenburg-Vorpommern” was not necessary as organs were taken from sacrificed mice and no experimental manipulations were performed (article 6 (1) sentence 6–9 German animal protection law). Animal housing was done by professional animal keepers and all efforts were made to minimize suffering.

Mice

C57BL/6 (Charles River, Wilmington, MA, USA), NMRI (Charles River, Wilmington, MA, USA), DBA/1 (Charles River, Wilmington, MA, USA), MRL/MpJ (Jackson Laboratory, Bar Harbor, ME, USA) and SKG (kind gift from Ulf Hamann, DRFZ in Berlin, Germany) mice were maintained in a specific pathogen free unit on a 12 hr light / 12 hr dark cycle with 30 min twilight period. The ambient temperature was 21±2°C, the humidity was 60±10% and the room air change is 20-fold. Mice were housed using a stocking density of 3–5 mice per cage. Mice were given water and ssniff R/M-H diet (ssniff Spezialdiäten GmbH, Soest, Germany) ad libitum.

Isolation of mature and immature mTECs

Thymic cells were isolated from 4–5 week old male mice according to a previously published workflow [15]. Mice were sacrificed by cervical dislocation prior to preparation of the thymus. Thymi from 5 mice were carefully excised and adjacent connective tissue was removed. Thymi were cut into small pieces and digested in 500 μl RPMI containing 0.02% collagenase B (Roche Deutschland Holding GmbH, Grenzach-Wyhlen, Germany), 2 U/ml dispase (BD Bioscience, San Jose, CA, USA) and 100 U/ml DNase (Roche Deutschland Holding GmbH, Grenzach-Wyhlen, Germany) per thymus. Thymic pieces were incubated at 37°C and cells were dissociated using glass pipettes with decreasing opening diameter. Single cell suspensions were centrifuged, resuspended in 4ml dense Percoll (density: 1.115 g/ml, Sigma Aldrich, St. Louis, MO, USA) and transferred into a 15 ml tube. On top of this cell suspension, 2ml of Percoll with a lower density (density: 1.065 g/ml) were layered and again on top, 2ml D-PBS (Gibco, Life Technologies, Carlsbad, CA, USA). Density gradient was established by centrifugation at 1450xg at 4°C for 30 min. TEC enriched in the second interphase were used for subsequent depletion of CD45⁺ cells using CD45-microbeads (clone: 30F11.1, Miltenyi, Bergisch Gladbach, Germany) according to manufacturer's instructions. CD45-depleted cells were stained for surface markers in ice-cold PBS pH 7.4, 0.5% bovine serum albumin, 0.1% sodium azide. The following antibodies were used: Ly-51:FITC (clone: 6C3, BD Bioscience, San Jose, CA, USA), CD80:PE (clone: 16-10A1, Biolegend, San Diego, CA, USA), CD45:PerCP (clone: 30-F11, Biolegend, San Diego, CA, USA), EpCAM:Alexa647 (clone: G8.8, Biolegend, San Diego, CA, USA). Immature mTEC (CD45^-EpCAM⁺Ly-51^-/lowCD80^low) and mature mTEC (CD45^-EpCAM⁺Ly-51^-/lowCD80^high) were sorted using a FACS Aria II machine (BD Bioscience, San Jose, CA, USA).

PAD mRNA expression analysis

mRNA isolation was performed using the RNeasy Plus Mini Kit (Qiagen, Venlo, Netherlands) according to the manufacturer's instructions. RNA concentration and quality was checked using the Agilent RNA 6000 Pico Kit (Agilent Technologies, Santa Clara, CA, USA) again, according to the manufacturer's instructions. The mean RNA integrity number was 8.2. Reverse transcription was performed using the High Capacity cDNA Reverese Transcription kit (Applied Biosystems, Life Technologies, Carlsbad, CA, USA) according to the manufacturer's instructions. TaqMan Gene Expression Assays (Applied Biosystems, Life Technologies, Carlsbad, CA, USA) were run for following genes: Aire (Mm0047746_m1), Psmb11 (Mm00613641_s1), Ins1 (Mm01950294_s1), Ins2 (Mm00731595_gH), Padi1 (Mm00478062_,1), Padi2 (Mm00447020_m1), Padi3 (Mm00478075_m1), Padi4 (Mm01341658_m1) and Padi6 (Mm00462201_m1). Ct values were normalized to Gapdh (Rodent gapdh control reagents, Applied Biosystems, Life Technologies, Carlsbad, CA, USA) by the formula 2^{-Δct(gene-gapdh)}.

Detection of citrullination by western blot

Protein lysates from FACS sorted mTECs were prepared by resuspending the cells in loading buffer (62.5 mM Tris/Hcl buffer pH 6.8 containing 2% sodium dodecyl sulfate, 65 mM dithiothreitol, 0.08% bromophenol blue and 380 mM glycerine). Lung and muscle protein lysates were prepared by traversing respective minced tissue through a 70μm cell strainer (BD Bioscience, San Jose, CA, USA) in lysis buffer (20mM Tris-HCl, pH 7.4, 10mM beta-mercaptoethanol, 100 mM NaCl, 10% glycerol). Samples were sonicated 3x for 10s each using a Laborette 19 rod sonifier at a strength of 2.2 (Fritsch GmbH, Idar-Oberstein, Germany) and passed three freeze/thaw cycles using liquid nitrogen. Thereafter, samples were centrifuged at 18,000xg at 4°C for 30 min. Supernatants were taken and diluted in loading buffer. Samples were then loaded on a Laemmli gel and SDS-PAGE was performed for 40 minutes at 220V in a miniVE Complete system (Hoefer Inc., Holliston, MA, USA). Protein was transferred to a Immobilon-FL membrane (Merck Millipore, Darmstadt, Germany) with a Trans-Blot SD Cell (Bio-Rad Laboratories GmbH, Munich, Germany). Ponceau staining was performed on the membrane to ensure sufficient protein transfer. Blocking was done over night at 4°C using Odyssey Blocking Buffer (LI-COR, Lincoln, NE, USA). Membranes were stained with 0.2μg/ml biotinylated anti-peptidyl-citrulline antibody raised against a citrullinated peptide consisting of 10 citrulline residues (clone F95, Merck Millipore, Darmstadt, Germany) or 0.1μg/ml anti-GAPDH antibody (clone 6C5, Abcam plc, Cambridge, UK) in Odyssey Blocking Buffer with 0.1% Tween-20 for 2 hours at room temperature. After washing Streptavidin-DyLight800 (Thermo Fisher Scientific, Waltham, MA, USA) or anti-mouse-IRDye680CW (LI-COR, Lincoln, NE, USA) were incubated in Odyssey Blocking Buffer with 0.1% Tween-20 for 1h to visualize citrulline or GAPDH staining, respectively. Membranes were scanned and bands quantified with a Odyssey CLx Scanner (LI-COR, Lincoln, NE, USA).

Immunofluorescence detection of citrullination

Thymi were excised, mounted onto a steel block by Tissuetek (Sakura Finetek, Alphen an den Rijn, Netherlands) and frozen in liquid nitrogen. 6 μm cryosections were prepared using a Carl Zeiss cryotome (Carl Zeiss Jena GmbH, Jena, Germany) and were mounted on glass slides. The sections were fixed for 10 min in -20°C pre-cooled acetone (LI-COR, Lincoln, NE, USA), and were then dried for 20 min at RT. They were washed two times for 5 min each with TBS-buffer. The sections were encircled with a wax pen (Thermo Fisher Scientific Inc., Waltham, MA, USA) and were blocked with blocking buffer (1x TBS containing 2.5% skim milk (USBiological, Salem, MA, USA) and 2.5% FCS (Biochrom GmbH, Berlin, Germany) for 1 h in a humidified chamber at RT. Primary reagents in the respective dilutions were added to the sections and incubated overnight in a humidified chamber at 4°C. Following primary reagents were used: rat-anti-mouse Aire IgG2 (clone 5H12; eBioscience San Diego, CA, USA; dilution: 1:100), rabbit anti-Cytokeratin 5 antibody (Covance, Princeton, NJ, USA; dilution: 1:1000), rabbit anti-citrullin (Abcam, Cambridge, UK; dilution: 1:500), Rabbit Serum (dilution 1:100), human ACPA-positive sera pool (dilution: 1:100), human ACPA-negative sera pool (dilution: 1:100) and UEA-1 lectin coupled to biotin (Vector Laboratories, Burlingame, CA, USA; dilution: 1:100). The sections were washed two times for 5 min each with TBS-buffer and the respective dilutions of the secondary reagents were added. Subsequently, the sections were incubated for 1 h at RT in a humidified chamber. As secondary reagents, the following antibodies were used: goat-anti-rat IgG Alexa488 (Molecular Probes, Life Technologies, Carlsbad, CA, USA; dilution: 1:500), goat-anti-rabbit IgG Alexa488 (Molecular Probes, Life Technologies, Carlsbad, CA, USA; dilution: 1:500), goat-anti-rabbit IgG Alexa546 (Molecular Probes, Life Technologies, Carlsbad, CA, USA; dilution: 1:500), goat-anti-human IgG Alexa488 (Molecular Probes, Life Technologies, Carlsbad, CA, USA; dilution: 1:500) and Streptavidin Alexa546 (Molecular Probes, Life Technologies, Carlsbad, CA, USA; dilution: 1:500). The sections were washed two times for 5 min each with TBS-buffer. DAPI (Molecular Probes, Life Technologies, Carlsbad, CA, USA; 1:1000 dilution) was added onto the sections and incubated for 15 min at room temperature. The sections were again washed two times for 5 min each with TBS-buffer, four times for 30 s each under running tap water and one time for 5 min with distilled water. The excess water was removed carefully from the slides and the sections were embedded in Fluorescence Mounting Medium (DiaSorin Inc., Stillwater, MN, USA). Confocal images were acquired using the LSM 780 (Carl Zeiss Jena GmbH, Jena, Germany) using the software ZEN2011.

Statistics

Statistical analyzes were performed in R (Version 3.1.2). Differences between two groups were tested by Mann-Whitney U-test or student’s T-test where appropriate. Correlations were calculated by Spearman's rank correlation. Confidence intervals were calculated by spearman.ci function (R-package: RVAideMemoire).

Results

Sorting of mature and immature mTEC

In order to investigate a promiscuous PAD expression in the medulla of the murine thymus, we first isolated the mTECs via FACS. To that extent we identified all TECs as CD45-negative and EpCAM-positive cells and then differentiated the Ly-51^hi cTECs from the Ly-51^lo/negative mTECs. Mature and immature mTECs were further differentiated on the basis of their CD80 expression (Fig 1A). We isolated mature and immature mTECs with mean purities of 86.9% and 88.5%, respectively (Fig 1B). As leukocytes were previously shown to express PAD isoforms [2], we thoroughly controlled our sorted cells for impurities. Indeed, the mean percentages of CD45-positive leukocytes among the sorted mature and immature mTECs were 2.1% and 1.6% only and thus negligible. The mean percentages of Ly-51^hi cTECs among sorted immature and mature mTECs were 3.6% and 0.1%, respectively. To further confirm the identity of both mTEC populations, we analyzed the expression of Aire and Ins2 as examples for an AIRE-dependent promiscous gene expression [16]. To that extent, we isolated the mRNA from the sorted cell populations and performed qRT-PCR for Gapdh as well as our genes of interest. We thus found a median 17-fold (IQR: 11.8; p<0.001) increased expression for Aire in mature compared to immature mTECs. Likewise, there was a 50-fold (IQR: 69.5; p<0.001) higher expression for Ins2 in mature mTECs compared to immature mTECs (Fig 1C).

Download:

Fig 1. Isolation of mature and immature mTECs from murine thymi.

(A) Flow cytometric analyses of thymic cells from NMRI mice, magnetically depleted of CD45-positive cells. TECs are identified as EpCAM-positive and CD45-negative cells (left panel). mTECs were considered as Ly-51^-/low cells (middle panel). According to their CD80-expression, we further discriminated mature mTECs (m-mTEC) and immature mTECs (im-mTEC) (right panel). (B) Re-analyses showed high purities of m-mTEC (right panel) and im-mTEC (middle panel). (C) mRNA expression of Aire and Ins2 was higher in mature compared to immature mTEC. Gapdh was used as the reference gene. Boxes show medians and quartiles. Data shown are pooled from C57BL/6, DBA/1, MRL/MpJ and SKG mice.

https://doi.org/10.1371/journal.pone.0158773.g001

PAD genes are readily expressed in mTEC

We next used the isolated mTECs to analyze the expression of the five Pad isoforms at the mRNA level. We could show, that out of the five Pad isoforms, four are significantly higher expressed in mature mTECs compared to immature mTECs (Pad1: 0.01 vs 0.001, p = 0.003; Pad3: 0.008 vs. 0.002, p = 0.02; Pad4: 0.02 vs. 0.005, p = 0.03; Pad6: 0.005 vs. 0.0003, p<0.001), whereas Pad2 showed no significant difference in the expression level between mature and immature mTECs (Pad2: 0.07 vs. 0.03, p = 0.13) (Pad expression in mature and immature mTECs is shown in Fig 2B). Interestingly, Pad2 showed the highest expression level in mature mTECs and was comparable to Ins2. In contrast, the other four Pad isoforms showed a significantly lower expression than Ins2 and—except for Pad4 –also a significant lower expression than Pad2 (Fig 2A). Therefore, we conclude that Pad2 and Pad4 are the main Pad isoforms expressed in mature mTECs in mice and their expression levels are comparable to Ins2. The comparison of Pad expression among various mouse strains—some of which are prone to the development of autoimmunity—showed no significant differences.

Download:

Fig 2. Pad-RNA is expressed in mTECs.

(A) mRNA expression of Aire, the tissue-restricted gene Ins2 as well as five Pad isoforms was analyzed in mature mTECs performing qPCR. Gapdh was used as a reference gene. Bars show mean +/- SEM (n = 20). p-values were calculated by t-test. (B) Aire expression is correlated to the expression of Ins2 and all five Pad isoforms. Open and closed circles indicate the expression in immature and mature mTEC, respectively. The correlation coefficients were calculated by Spearman test. All p-values were below 0.001. The results shown are pooled data derived from experiments performed with C57BL/6, DBA/1, MRL/MpJ and SKG mice.

https://doi.org/10.1371/journal.pone.0158773.g002

Of note, we did find significant correlations between the expression of Aire and Ins2 (R = 0.84, CI 0.71–0.91), as well as between Aire and all five Pad isoforms (Pad1: R = 0.85, CI 0.63–0.95; Pad2: R = 0.68, CI 0.43–0.82; Pad3: R = 0.78, CI 0.59–0.89; Pad4: R = 0.72, CI 0.44–0.88 and Pad6: R = 0.88, CI 0.76–0.93) (Fig 2B).

Citrullination is present in mTECs and in the medulla of the thymus

The appearance of Pad mRNA in murine mTECs prompted us to investigate whether citrullination does take place in these cells. Therefore, we took two independent approaches. Firstly, we isolated protein from FACS sorted mTECs and performed a western blot including muscle tissue and liver lysate as positive and negative controls, respectively. As shown in Fig 3A we clearly could detect multiple bands stained with the F95 anti-citrulline antibody in the lysates of mTECs and muscle. As expected, liver lysates completely lacked the staining for citrullination except for a single weak band at around 90 kDa. We analyzed the relative expression of this band in reference to the GAPDH expression in all three lysates and found the highest relative expression in mTECs (28-fold), followed by muscle (21-fold) and liver (0.75-fold).

Download:

Fig 3. Citrullination is present in isolated mTEC and within medullary areas of the thymus.

(A) Western blot to detect citrullination (clone F95) and the reference protein (GAPDH) in lysates from FACS sorted mTECs, muscle (positive control) and liver (negative control). The arrow indicates the band present in all samples that was used for a relative expression analysis with respect to GAPDH (arrowhead): muscle: 21-fold, mTEC: 28-fold and liver: 0.75-fold. Numbers within the band of the protein marker lane indicate protein sizes in kDa. (B) Identification of mTEC in thin sections of murine thymi by dual immunofluorescence staining with anti-Aire (green) and anti-cytokeratin 5 (red) or UEA-1 (red). (C) Detection of citrullination in mTEC areas of thymic thin sections. mTECs were stained with UEA-1 (red) and RA-specific epitopes are labeled with an ACPA-high serum mixture consisting of three RA patient's sera (green) (upper right panel). A mix of two age-matched healthy control sera was used as negative control (upper left panel). Staining with a rabbit anti-citrulline serum (green) shows citrullination within mTEC areas (lower right panel). Rabbit normal serum was used as a negative control (lower left panel). All results shown were derived from NMRI thymi.

https://doi.org/10.1371/journal.pone.0158773.g003

Secondly, we performed immunofluorescence on thymic thin sections. We identified mTECs in these thin sections of mouse thymi by staining with antibodies against cytokeratin 5 and AIRE as well as with the lectin UEA-1 (Fig 3B). The detection of citrullination was performed two-fold: First, we mixed sera of three ACPA-high RA-patients and used the mix of two age and sex-matched healthy control sera as a negative control. While there was no staining with the negative control sera, we could show a clear staining with the ACPA-positive sera within mTEC areas of murine thymi (Fig 3C). Thus, epitopes recognized by RA-specific antibodies exist within the thymic medulla. In a next step, we directly showed citrullination by using an anti-citrulline antibody. Indeed, we could demonstrate that citrullinated proteins are present within the mTEC areas of mouse thymi (Fig 3C). These results hold true for all mouse strains investigated and do not reveal any strain-specific differences.

Discussion

We here demonstrate the expression of Pad isoforms in murine mTECs. We also show that Pad2 is expressed at a comparable level with Ins2 and Pad4 and we therefore conclude that Pad2 and Pad4 are the main Pad isoforms expressed in murine mTECs. Interestingly, PAD2 and PAD4 have also been shown to be upregulated in monocytes and macrophages of the RA synovium and that they contribute to the citrullination of synovial proteins [17]. It can therefore be anticipated, that the very same epitopes become citrullinated in mature mTEC as well as in the RA synovium.

We further analyzed whether citrullination—the result from PAD protein expression and PAD activity—does take place in mTECs. Indeed, performing Western Blot analyses, we demonstrated that murine mTECs express citrullinated proteins at a level comparable to muscle tissue. Of note, lysates from murine muscle tissue but not from liver were previously shown to exhibit a high PAD activity [18]. As a second independent method, we performed immunofluorescence on thymic thin sections and we here show that citrullinated epitopes are present in medullary areas. These citrullinated epitopes are recognized by both, the sera of ACPA-positive RA patients and a peptidylcitrulline-specific antibody, whereas sera of age matched ACPA-negative controls and rabbit normal serum did not bind. In summary, our data indicate that the prerequisites for a negative selection of peptidylcitrulline-specific T cells in the thymus are met. However, because we did not investigate negative selection itself, we cannot predict whether peptidylcitrulline-specific T cells manage to escape into the periphery. Moreover, it needs to be determined whether thymocytes can be induced to differentiate into peptidylcitrulline-specific regulatory T cells. It therefore remains an open question whether autoimmunity in RA is driven by a failure of central or peripheral tolerance mechanisms [19–20].

Ins2 has previously been shown to be expressed in an AIRE-dependent manner [21]. In line with this, we found a correlation between the expression levels of Ins2 and Aire. In addition, we found correlations between Aire expression and the expression of Pad isoforms. This is suggestive of Pad genes also being regulated by the transcriptional regulator AIRE, even though we do not yet have a formal proof for a direct regulation. Interestingly, a recent genetic association study in human RA patients linked an allelic variation in the fifth exon of AIRE to an increased susceptibility for RA. This variation is associated with a lower expression of AIRE [22]. One may therefore speculate, that a lower AIRE expression in individuals carrying the variation can also lead to a decreased expression of PAD isoforms, and subsequently to a reduced citrullination in mTECs which in turn can result in an increased frequency of peptidylcitrulline-specific T cells escaping central tolerance.

In summary, we here conclude that the prerequisites for a negative selection of peptidylcitrulline-specific T cells are met in the murine thymus. Ongoing experiments are underway to address whether this holds true for the human situation and whether T cells are actually negatively selected against citrullinated epitopes.

Supporting Information

S1 File. TaqMan data summary.

Delta Ct values expressed as 2^(-deltaCt(gene-gapdh)) grouped for mature and immature mTECs as well as for mouse strain.

https://doi.org/10.1371/journal.pone.0158773.s001

(CSV)

Author Contributions

Conceived and designed the experiments: RE BMH. Performed the experiments: RE AC AJ AB DK. Analyzed the data: RE AC AJ AB DK BHM. Wrote the paper: RE BMH.

References

1. Lundström E, Källberg H, Alfredsson L, Klareskog L, Padyukov L. Gene-environment interaction between the DRB1 shared epitope and smoking in the risk of anti-citrullinated protein antibody-positive rheumatoid arthritis: All alleles are important. Arthritis Rheum 2009;60:1597–1603. pmid:19479873
- View Article
- PubMed/NCBI
- Google Scholar
2. Vossenaar ER, Zendman AJW, van Venrooij WJ, Pruijn GJM. PAD, a growing family of citrullinating enzymes: genes, features and involvement in disease. BioEssays 2003;25:1106–1118. pmid:14579251
- View Article
- PubMed/NCBI
- Google Scholar
3. Darrah E, Rosen A, Giles JT, Andrade F. Peptidylarginine deiminase 2, 3 and 4 have distinct specificities against cellular substrates: Novel insights into autoantigen selection in rheumatoid arthritis. Ann Rheum Dis 2012;71:92–98. pmid:21859690
- View Article
- PubMed/NCBI
- Google Scholar
4. Makrygiannakis D, af Klint E, Lundberg IE, Löfberg R, Ulfgren A-K, Klareskog L, et al. Citrullination is an inflammation-dependent process. Ann Rheum Dis 2006;65:1219–1222. pmid:16540548
- View Article
- PubMed/NCBI
- Google Scholar
5. Bos WH, Stadt LA van de , Sohrabian A, Rönnelid J, van Schaardenburg D. Development of anti-citrullinated protein antibody and rheumatoid factor isotypes prior to the onset of rheumatoid arthritis. Arthritis Res Ther 2014;16:405. pmid:25167340
- View Article
- PubMed/NCBI
- Google Scholar
6. Kidd BA, Ho PP, Sharpe O, Zhao X, Tomooka BH, Kanter JL, et al. Epitope spreading to citrullinated antigens in mouse models of autoimmune arthritis and demyelination. Arthritis Res Ther 2008;10:R119. pmid:18826638
- View Article
- PubMed/NCBI
- Google Scholar
7. Lundberg K, Nijenhuis S, Vossenaar ER, Palmblad K, van Venrooij WJ, Klareskog L, et al. Citrullinated proteins have increased immunogenicity and arthritogenicity and their presence in arthritic joints correlates with disease severity. Arthritis Res Ther 2005;7:R458. pmid:15899032
- View Article
- PubMed/NCBI
- Google Scholar
8. Kuhn KA, Kulik L, Tomooka B, Braschler KJ, Arend WP, Robinson WH, et al. Antibodies against citrullinated proteins enhance tissue injury in experimental autoimmune arthritis. J Clin Invest 2006;116:961–973. pmid:16585962
- View Article
- PubMed/NCBI
- Google Scholar
9. Thiele GM, Duryee MJ, Dusad A, Hunter CD, Lacy JP, Anderson DR, et al. Citrullinated mouse collagen administered to DBA/1J mice in the absence of adjuvant initiates arthritis. Int Immunopharmacol 2012;13:424–431. pmid:22626832
- View Article
- PubMed/NCBI
- Google Scholar
10. Anderson G, Takahama Y. Thymic epithelial cells: working class heroes for T cell development and repertoire selection. Trends Immunol 2012;33:256–263. pmid:22591984
- View Article
- PubMed/NCBI
- Google Scholar
11. Derbinski J, Schulte A, Kyewski B, Klein L. Promiscuous gene expression in medullary thymic epithelial cells mirrors the peripheral self. Nat Immunol 2001;2:1032–1039. pmid:11600886
- View Article
- PubMed/NCBI
- Google Scholar
12. Velthuis JH, Unger WW, Abreu JRF, Duinkerken G, Franken K, Peakman M, et al. Simultaneous Detection of Circulating Autoreactive CD8+ T-Cells Specific for Different Islet Cell–Associated Epitopes Using Combinatorial MHC Multimers. Diabetes 2010;59:1721–1730. pmid:20357361
- View Article
- PubMed/NCBI
- Google Scholar
13. Cowan JE, Parnell SM, Nakamura K, Caamano JH, Lane PJL, Jenkinson EJ, et al. The thymic medulla is required for Foxp3+ regulatory but not conventional CD4+ thymocyte development. J Exp Med 2013;210:675–681. pmid:23530124
- View Article
- PubMed/NCBI
- Google Scholar
14. Martinez RJ, Zhang N, Thomas SR, Nandiwada SL, Jenkins MK, Binstadt BA, et al. Arthritogenic self-reactive CD4+ T cells acquire an FR4hiCD73hi anergic state in the presence of Foxp3+ regulatory T cells. J Immunol 2012;188:170–181. pmid:22124124
- View Article
- PubMed/NCBI
- Google Scholar
15. Derbinski J, Pinto S, Rösch S, Hexel K, Kyewski B. Promiscuous gene expression patterns in single medullary thymic epithelial cells argue for a stochastic mechanism. PNAS 2008;105:657–662. pmid:18180458
- View Article
- PubMed/NCBI
- Google Scholar
16. Fan Y, Rudert WA, Grupillo M, He J, Sisino G, Trucco M. Thymus-specific deletion of insulin induces autoimmune diabetes. EMBO J 2009;28:2812–2824. pmid:19680229
- View Article
- PubMed/NCBI
- Google Scholar
17. Vossenaar E, Radstake T, van der Heijden A, van Mansum MAM, Dieteren C, de Rooij D-J, et al. Expression and activity of citrullinating peptidylarginine deiminase enzymes in monocytes and macrophages. Ann Rheum Dis 2004;63:373–381. pmid:15020330
- View Article
- PubMed/NCBI
- Google Scholar
18. van Beers JJBC, Zendman AJW, Raijmakers R, Stammen-Vogelzangs J, Pruijn GJM. Peptidylarginine deiminase expression and activity in PAD2 knock-out and PAD4-low mice. Biochimie 2013;95: 299–308. pmid:23026755
- View Article
- PubMed/NCBI
- Google Scholar
19. Ehrenstein MR, Evans JG, Singh A, Moore S, Warnes G, Isenberg DA, et al. Compromised Function of Regulatory T Cells in Rheumatoid Arthritis and Reversal by Anti-TNFα Therapy. J Exp Med 2004;200:277–285. pmid:15280421
- View Article
- PubMed/NCBI
- Google Scholar
20. Frey O, Petrow PK, Gajda M, Siegmund K, Huehn J, Scheffold A, et al. The role of regulatory T cells in antigen-induced arthritis: aggravation of arthritis after depletion and amelioration after transfer of CD4+CD25+ T cells. Arthritis Res Ther 2005;7:R291–R301. pmid:15743476
- View Article
- PubMed/NCBI
- Google Scholar
21. Derbinski J, Gäbler J, Brors B, Tierling S, Jonnakuty S, Hergenhahn M, et al. Promiscuous gene expression in thymic epithelial cells is regulated at multiple levels. J Exp Med 2005;202:33–45. pmid:15983066
- View Article
- PubMed/NCBI
- Google Scholar
22. Garcia-Lozano J-R, Torres-Agrela B, Montes-Cano M-A, Ortiz-Fernandez L, Conde-Jaldon M, Teruel M, et al. Association of the AIRE gene with susceptibility to rheumatoid arthritis in a European population: a case control study. Arthritis Res Ther 2013;15:R11. pmid:23320549
- View Article
- PubMed/NCBI
- Google Scholar

[ref1] 1. Lundström E, Källberg H, Alfredsson L, Klareskog L, Padyukov L. Gene-environment interaction between the DRB1 shared epitope and smoking in the risk of anti-citrullinated protein antibody-positive rheumatoid arthritis: All alleles are important. Arthritis Rheum 2009;60:1597–1603. pmid:19479873
View Article
PubMed/NCBI
Google Scholar

[2] View Article

[3] PubMed/NCBI

[4] Google Scholar

[ref2] 2. Vossenaar ER, Zendman AJW, van Venrooij WJ, Pruijn GJM. PAD, a growing family of citrullinating enzymes: genes, features and involvement in disease. BioEssays 2003;25:1106–1118. pmid:14579251
View Article
PubMed/NCBI
Google Scholar

[6] View Article

[7] PubMed/NCBI

[8] Google Scholar

[ref3] 3. Darrah E, Rosen A, Giles JT, Andrade F. Peptidylarginine deiminase 2, 3 and 4 have distinct specificities against cellular substrates: Novel insights into autoantigen selection in rheumatoid arthritis. Ann Rheum Dis 2012;71:92–98. pmid:21859690
View Article
PubMed/NCBI
Google Scholar

[10] View Article

[11] PubMed/NCBI

[12] Google Scholar

[ref4] 4. Makrygiannakis D, af Klint E, Lundberg IE, Löfberg R, Ulfgren A-K, Klareskog L, et al. Citrullination is an inflammation-dependent process. Ann Rheum Dis 2006;65:1219–1222. pmid:16540548
View Article
PubMed/NCBI
Google Scholar

[14] View Article

[15] PubMed/NCBI

[16] Google Scholar

[ref5] 5. Bos WH, Stadt LA van de , Sohrabian A, Rönnelid J, van Schaardenburg D. Development of anti-citrullinated protein antibody and rheumatoid factor isotypes prior to the onset of rheumatoid arthritis. Arthritis Res Ther 2014;16:405. pmid:25167340
View Article
PubMed/NCBI
Google Scholar

[18] View Article

[19] PubMed/NCBI

[20] Google Scholar

[ref6] 6. Kidd BA, Ho PP, Sharpe O, Zhao X, Tomooka BH, Kanter JL, et al. Epitope spreading to citrullinated antigens in mouse models of autoimmune arthritis and demyelination. Arthritis Res Ther 2008;10:R119. pmid:18826638
View Article
PubMed/NCBI
Google Scholar

[22] View Article

[23] PubMed/NCBI

[24] Google Scholar

[ref7] 7. Lundberg K, Nijenhuis S, Vossenaar ER, Palmblad K, van Venrooij WJ, Klareskog L, et al. Citrullinated proteins have increased immunogenicity and arthritogenicity and their presence in arthritic joints correlates with disease severity. Arthritis Res Ther 2005;7:R458. pmid:15899032
View Article
PubMed/NCBI
Google Scholar

[26] View Article

[27] PubMed/NCBI

[28] Google Scholar

[ref8] 8. Kuhn KA, Kulik L, Tomooka B, Braschler KJ, Arend WP, Robinson WH, et al. Antibodies against citrullinated proteins enhance tissue injury in experimental autoimmune arthritis. J Clin Invest 2006;116:961–973. pmid:16585962
View Article
PubMed/NCBI
Google Scholar

[30] View Article

[31] PubMed/NCBI

[32] Google Scholar

[ref9] 9. Thiele GM, Duryee MJ, Dusad A, Hunter CD, Lacy JP, Anderson DR, et al. Citrullinated mouse collagen administered to DBA/1J mice in the absence of adjuvant initiates arthritis. Int Immunopharmacol 2012;13:424–431. pmid:22626832
View Article
PubMed/NCBI
Google Scholar

[34] View Article

[35] PubMed/NCBI

[36] Google Scholar

[ref10] 10. Anderson G, Takahama Y. Thymic epithelial cells: working class heroes for T cell development and repertoire selection. Trends Immunol 2012;33:256–263. pmid:22591984
View Article
PubMed/NCBI
Google Scholar

[38] View Article

[39] PubMed/NCBI

[40] Google Scholar

[ref11] 11. Derbinski J, Schulte A, Kyewski B, Klein L. Promiscuous gene expression in medullary thymic epithelial cells mirrors the peripheral self. Nat Immunol 2001;2:1032–1039. pmid:11600886
View Article
PubMed/NCBI
Google Scholar

[42] View Article

[43] PubMed/NCBI

[44] Google Scholar

[ref12] 12. Velthuis JH, Unger WW, Abreu JRF, Duinkerken G, Franken K, Peakman M, et al. Simultaneous Detection of Circulating Autoreactive CD8+ T-Cells Specific for Different Islet Cell–Associated Epitopes Using Combinatorial MHC Multimers. Diabetes 2010;59:1721–1730. pmid:20357361
View Article
PubMed/NCBI
Google Scholar

[46] View Article

[47] PubMed/NCBI

[48] Google Scholar

[ref13] 13. Cowan JE, Parnell SM, Nakamura K, Caamano JH, Lane PJL, Jenkinson EJ, et al. The thymic medulla is required for Foxp3+ regulatory but not conventional CD4+ thymocyte development. J Exp Med 2013;210:675–681. pmid:23530124
View Article
PubMed/NCBI
Google Scholar

[50] View Article

[51] PubMed/NCBI

[52] Google Scholar

[ref14] 14. Martinez RJ, Zhang N, Thomas SR, Nandiwada SL, Jenkins MK, Binstadt BA, et al. Arthritogenic self-reactive CD4+ T cells acquire an FR4hiCD73hi anergic state in the presence of Foxp3+ regulatory T cells. J Immunol 2012;188:170–181. pmid:22124124
View Article
PubMed/NCBI
Google Scholar

[54] View Article

[55] PubMed/NCBI

[56] Google Scholar

[ref15] 15. Derbinski J, Pinto S, Rösch S, Hexel K, Kyewski B. Promiscuous gene expression patterns in single medullary thymic epithelial cells argue for a stochastic mechanism. PNAS 2008;105:657–662. pmid:18180458
View Article
PubMed/NCBI
Google Scholar

[58] View Article

[59] PubMed/NCBI

[60] Google Scholar

[ref16] 16. Fan Y, Rudert WA, Grupillo M, He J, Sisino G, Trucco M. Thymus-specific deletion of insulin induces autoimmune diabetes. EMBO J 2009;28:2812–2824. pmid:19680229
View Article
PubMed/NCBI
Google Scholar

[62] View Article

[63] PubMed/NCBI

[64] Google Scholar

[ref17] 17. Vossenaar E, Radstake T, van der Heijden A, van Mansum MAM, Dieteren C, de Rooij D-J, et al. Expression and activity of citrullinating peptidylarginine deiminase enzymes in monocytes and macrophages. Ann Rheum Dis 2004;63:373–381. pmid:15020330
View Article
PubMed/NCBI
Google Scholar

[66] View Article

[67] PubMed/NCBI

[68] Google Scholar

[ref18] 18. van Beers JJBC, Zendman AJW, Raijmakers R, Stammen-Vogelzangs J, Pruijn GJM. Peptidylarginine deiminase expression and activity in PAD2 knock-out and PAD4-low mice. Biochimie 2013;95: 299–308. pmid:23026755
View Article
PubMed/NCBI
Google Scholar

[70] View Article

[71] PubMed/NCBI

[72] Google Scholar

[ref19] 19. Ehrenstein MR, Evans JG, Singh A, Moore S, Warnes G, Isenberg DA, et al. Compromised Function of Regulatory T Cells in Rheumatoid Arthritis and Reversal by Anti-TNFα Therapy. J Exp Med 2004;200:277–285. pmid:15280421
View Article
PubMed/NCBI
Google Scholar

[74] View Article

[75] PubMed/NCBI

[76] Google Scholar

[ref20] 20. Frey O, Petrow PK, Gajda M, Siegmund K, Huehn J, Scheffold A, et al. The role of regulatory T cells in antigen-induced arthritis: aggravation of arthritis after depletion and amelioration after transfer of CD4+CD25+ T cells. Arthritis Res Ther 2005;7:R291–R301. pmid:15743476
View Article
PubMed/NCBI
Google Scholar

[78] View Article

[79] PubMed/NCBI

[80] Google Scholar

[ref21] 21. Derbinski J, Gäbler J, Brors B, Tierling S, Jonnakuty S, Hergenhahn M, et al. Promiscuous gene expression in thymic epithelial cells is regulated at multiple levels. J Exp Med 2005;202:33–45. pmid:15983066
View Article
PubMed/NCBI
Google Scholar

[82] View Article

[83] PubMed/NCBI

[84] Google Scholar

[ref22] 22. Garcia-Lozano J-R, Torres-Agrela B, Montes-Cano M-A, Ortiz-Fernandez L, Conde-Jaldon M, Teruel M, et al. Association of the AIRE gene with susceptibility to rheumatoid arthritis in a European population: a case control study. Arthritis Res Ther 2013;15:R11. pmid:23320549
View Article
PubMed/NCBI
Google Scholar

[86] View Article

[87] PubMed/NCBI

[88] Google Scholar

Figures

Abstract

Objectives

Methods

Results

Conclusions

Introduction

Methods

Ethics Statement

Mice

Isolation of mature and immature mTECs

PAD mRNA expression analysis

Detection of citrullination by western blot

Immunofluorescence detection of citrullination

Statistics

Results

Sorting of mature and immature mTEC

PAD genes are readily expressed in mTEC

Citrullination is present in mTECs and in the medulla of the thymus

Discussion

Supporting Information

S1 File. TaqMan data summary.

Author Contributions

References